Chemokines and their receptors in infectious disease

[1]  Kazushi Nakano,et al.  Human Herpesvirus 7 Open Reading Frame U12 Encodes a Functional β-Chemokine Receptor , 2003, Journal of Virology.

[2]  J. Hoxie,et al.  Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.

[3]  M. Carrington,et al.  Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy , 2000, AIDS.

[4]  E. Génin,et al.  Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. , 2000, Science.

[5]  M. Loda,et al.  Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 , 2000, Nature.

[6]  Tong-Yuan Yang,et al.  Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma , 2000, The Journal of experimental medicine.

[7]  A. Alcamí,et al.  A Broad Spectrum Secreted Chemokine Binding Protein Encoded by a Herpesvirus , 2000, Journal of Experimental Medicine.

[8]  U. Wahn,et al.  Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES1 , 2000, The Journal of Immunology.

[9]  J. Kaldor,et al.  CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors , 2000, AIDS.

[10]  C. Barbas,et al.  Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Mangano,et al.  Protective Effect of CCR2‐64I and Not of CCR5‐&Dgr;32 and SDF1‐3′A in Pediatric HIV‐1 Infection , 2000, Journal of acquired immune deficiency syndromes.

[12]  A. Mangano,et al.  Protective effect of CCR2-64I and not of CCR5-Δ32 and SDF1-3'A in pediatric HIV-1 infection , 2000 .

[13]  E. De Clercq,et al.  A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry. , 2000, Molecular pharmacology.

[14]  G. McFadden,et al.  Use of chemokine receptors by poxviruses. , 1999, Science.

[15]  B. Korber,et al.  A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants , 1999, Journal of Virology.

[16]  N. Maeda,et al.  Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. , 1999, Journal of immunology.

[17]  M J Dolan,et al.  Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Gazzard,et al.  Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. , 1999, The Journal of infectious diseases.

[19]  W. Ollier,et al.  A polymorphism at position -403 in the human RANTES promoter. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[20]  W. Ollier,et al.  A rare polymorphism at position -28 in the human RANTES promoter. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[21]  T. Schall,et al.  Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Mantovani,et al.  A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. , 1999, European cytokine network.

[23]  J. Goedert,et al.  Phenotypic Expressions of CCR5-Δ32/Δ32 Homozygosity , 1999 .

[24]  J. Weiss,et al.  HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. , 1999, Journal of immunology.

[25]  V. Sasseville,et al.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.

[26]  C. Davis,et al.  Fully human anti‐interleukin‐8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states , 1999, Journal of leukocyte biology.

[27]  E. De Clercq,et al.  Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4. , 1999, Journal of medicinal chemistry.

[28]  M. Lederman,et al.  Association of the CCR5delta32 mutation with improved response to antiretroviral therapy. , 1999, JAMA.

[29]  C. Martínez-A,et al.  Chemokine control of HIV-1 infection , 1999, Nature.

[30]  T. Schall,et al.  Cytomegalovirus encodes a potent alpha chemokine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Moroni,et al.  Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. , 1999, The Journal of infectious diseases.

[32]  E. De Clercq,et al.  Shift of Clinical Human Immunodeficiency Virus Type 1 Isolates from X4 to R5 and Prevention of Emergence of the Syncytium-Inducing Phenotype by Blockade of CXCR4 , 1999, Journal of Virology.

[33]  K. Yamanishi,et al.  Human Herpesvirus 6 Open Reading Frame U83 Encodes a Functional Chemokine , 1999, Journal of Virology.

[34]  A. Haase,et al.  Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis , 1999, Journal of Virology.

[35]  H. Takaku,et al.  Antisense oligodeoxynucleotide complementary to CXCR4 mRNA block replication of HIV-1 in COS cells. , 1999, Nucleosides & nucleotides.

[36]  O. Nishimura,et al.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Voevodin,et al.  Frequencies of SDF‐1 chemokine, CCR‐5, and CCR‐2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis , 1999, Journal of medical virology.

[38]  S. Arya,et al.  In vitro phenotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo. , 1999, Journal of human virology.

[39]  William C. Olson,et al.  Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5 , 1999, Journal of Virology.

[40]  K Fukutake,et al.  Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. McFadden,et al.  Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. , 1999, Virology.

[42]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. MacDonald,et al.  CCR2-64I Polymorphism Is Not Associated with Altered CCR5 Expression or Coreceptor Function , 1999, Journal of Virology.

[44]  D. Littman,et al.  Fusion-competent vaccines: broad neutralization of primary isolates of HIV. , 1999, Science.

[45]  A. Trkola,et al.  Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion , 1999, Journal of Virology.

[46]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[47]  J. Goedert,et al.  Phenotypic expressions of CCR5-delta32/delta32 homozygosity. , 1999, Journal of acquired immune deficiency syndromes.

[48]  X Zhang,et al.  A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. , 1998, Biochemical and biophysical research communications.

[49]  D. Ho,et al.  Natural Infection of a Homozygous Δ24 CCR5 Red-capped Mangabey with an R2b-Tropic Simian Immunodeficiency Virus , 1998, The Journal of experimental medicine.

[50]  J. Goedert,et al.  Genetic acceleration of AIDS progression by a promoter variant of CCR5. , 1998, Science.

[51]  Dan R. Littman,et al.  Use of Coreceptors Other Than CCR5 by Non-Syncytium-Inducing Adult and Pediatric Isolates of Human Immunodeficiency Virus Type 1 Is Rare In Vitro , 1998, Journal of Virology.

[52]  Irene Bosch,et al.  Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains , 1998, Journal of Virology.

[53]  A. Bernad,et al.  A hammerhead ribozyme targeted to the human chemokine receptor CCR5. , 1998, Biochemical and biophysical research communications.

[54]  E. De Clercq,et al.  CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity. , 1998, Antiviral research.

[55]  J. Hoxie,et al.  CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  C. Kleeberger,et al.  CCR5 promoter polymorphism and HIV-1 disease progression , 1998, The Lancet.

[57]  C. Vita,et al.  Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells , 1998, The Journal of experimental medicine.

[58]  R. Doms,et al.  Influence of the CCR2-V64I Polymorphism on Human Immunodeficiency Virus Type 1 Coreceptor Activity and on Chemokine Receptor Function of CCR2b, CCR3, CCR5, and CXCR4 , 1998, Journal of Virology.

[59]  Zhiwei Chen,et al.  Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus , 1998, Current Biology.

[60]  P. O’Connell,et al.  Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression , 1998, Nature Medicine.

[61]  F. Torti,et al.  Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines , 1998, Gene Therapy.

[62]  D. Taub,et al.  Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor* , 1998, The Journal of Biological Chemistry.

[63]  H. Schuitemaker,et al.  The role of a stromal cell‐derived factor‐1 chemokine gene variant in the clinical course of HIV‐1 infection , 1998, AIDS.

[64]  M. Hollingshead,et al.  Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application. , 1998, Journal of medicinal chemistry.

[65]  H. Ostrer,et al.  Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. , 1998, American journal of human genetics.

[66]  B. Moss,et al.  Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Michael Greenberg,et al.  Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4 , 1998, Current Biology.

[68]  J. Grivel,et al.  Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. , 1998, The Journal of clinical investigation.

[69]  R. Hertzberg,et al.  Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.

[70]  R. Bravo,et al.  Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. , 1998, Journal of immunology.

[71]  L. Peltonen,et al.  The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. , 1998, Human molecular genetics.

[72]  J. Phair,et al.  A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation , 1998, Nature Medicine.

[73]  J J Goedert,et al.  Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) , 1998, Science.

[74]  B. Korber,et al.  A new classification for HIV-1 , 1998, Nature.

[75]  Luc Montagnier,et al.  HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene , 1998, The Lancet.

[76]  E. Cesarman,et al.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[77]  K. Yamanishi,et al.  Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. , 1998, Journal of virology.

[78]  Kuan-Teh Jeang,et al.  Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.

[79]  M. Ditto,et al.  Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage , 1997, The Journal of experimental medicine.

[80]  J. Schlessinger,et al.  Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5 , 1997, The Journal of experimental medicine.

[81]  R. Bravo,et al.  Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor , 1997, The Journal of experimental medicine.

[82]  D. Weissman,et al.  Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor , 1997, Nature.

[83]  R. Doms,et al.  A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor , 1997, The Journal of experimental medicine.

[84]  C. Boshoff,et al.  Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. , 1997, Science.

[85]  A. Yang,et al.  Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy , 1997, Nature Medicine.

[86]  T. Schwartz,et al.  A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. , 1997, Science.

[87]  J. Rose,et al.  Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection , 1997, Cell.

[88]  S. Finke,et al.  A CXCR4/CD4 Pseudotype Rhabdovirus That Selectively Infects HIV-1 Envelope Protein-Expressing Cells , 1997, Cell.

[89]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[90]  A. Lazzarin,et al.  Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele , 1997, The Journal of experimental medicine.

[91]  E. De Clercq,et al.  Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. , 1997, Antiviral research.

[92]  Jean Salamero,et al.  HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.

[93]  N. Heveker,et al.  Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. , 1997, Science.

[94]  T. Standiford,et al.  MCP-1 protects mice in lethal endotoxemia. , 1997, The Journal of clinical investigation.

[95]  H. Broxmeyer,et al.  Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.

[96]  C. Winkler,et al.  HIV-1 infection in a man homozygous for CCR5▵32 , 1997, The Lancet.

[97]  M. Carrington,et al.  HIV-1 infection in a man homozygous for CCR5 delta 32. , 1997, Lancet.

[98]  B. Bennetts,et al.  HIV-1 infection in an individual homozygous for the CCR5 deletion allele , 1997, Nature Medicine.

[99]  J. Sodroski,et al.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.

[100]  D. Weissman,et al.  Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk , 1997, Molecular medicine.

[101]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[102]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[103]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[104]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[105]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[106]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[107]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[108]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[109]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[110]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[111]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[112]  J. McCune,et al.  Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry , 1996, Antimicrobial agents and chemotherapy.

[113]  G. McFadden,et al.  Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. , 1996, Virology.

[114]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[115]  P. Tarr,et al.  Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[116]  B. Rollins,et al.  High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. , 1995, Journal of immunology.

[117]  J. Sheridan,et al.  Requirement of MIP-1 alpha for an inflammatory response to viral infection. , 1995, Science.

[118]  C. Tournamille,et al.  Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.

[119]  S. Arya,et al.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.

[120]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[121]  D. Danilenko,et al.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. , 1994, The Journal of clinical investigation.

[122]  P. Murphy,et al.  Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. , 1993, The Journal of biological chemistry.

[123]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.

[124]  W. Eling,et al.  Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice , 1993, Antimicrobial Agents and Chemotherapy.

[125]  K. Yamanishi.  Human Herpesvirus 6 , 1992, Microbiology and immunology.

[126]  L. Miller,et al.  The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.